Gains of chromosome 7 (involving EGFR) and losses of chromosome 10 (involving PTEN) are hallmarks of GBM, leading to enhanced tumor cell proliferation, survival, and invasion, ultimately contributing to the rapid growth and poor prognosis of GBM. This evidence concerns the gene EGFR and glioblastoma.